New product development (NPD) is a path not a destination; a path that organisations, more than ever, should follow to survive in the present unpredictable and dynamic market. Prospector organisations, especially those whom are leaders in their own industrial sector, implement some factors to improve new product success rate. In this regard, by applying a sequential mixed method approach, 13 key factors are identified and categorised into managerial, structural and organisational, process and environmental factors. Through identifying, analysing and verifying importance of these factors, this research aims to bridge the gap between theoretical studies and practical subjects of NPD.
New product development is considered as one of the survival strategies for organisations with high risk which is related to extreme failure rate that should not be neglected. Among internal and contextual factors which affect winning or losing in new product development (NPD), the role of top management team as key decision makers is critical. The objective of our research is to explore managerial factors influencing success in new product development. To find out these factors, relevant literature was reviewed and specific top managers were interviewed. Afterwards, a survey was administrated to elicit the opinions of managers involved in NPD in accordance to the degree of each factor's importance. This study examined six factors assumed to be critical in top management level to achieve success in NPD including commitment, regulatory focus, entrepreneurial orientation, social capital, international orientation and tendency of top managers to future study.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.